Abstract:
Remedies/preventives for respiratory diseases containing as the active ingredient compounds represented by general formula (1) or salts thereof: (1)(wherein R represents linear, branched or cyclic C1-10 alkyl; and R represents hydrogen, halogeno, substituted alkyl, optionally substituted amino, carboxy, alkoxycarbonyl, carbamoyl or alkylcarbamoyl). These compounds have excellent bronchodilating and respiratory tract contraction-inhibitory effects.
Abstract translation:含有作为由通式(1)表示的活性成分化合物或其盐的呼吸系统疾病的治疗/预防措施:(1)(其中R 1表示直链,支链或环状的C 1-10烷基; R 2表示氢 ,卤代,取代的烷基,任选取代的氨基,羧基,烷氧基羰基,氨基甲酰基或烷基氨基甲酰基)。 这些化合物具有优异的支气管扩张和呼吸道收缩抑制作用。
Abstract:
Compounds represented by general formula (I) (wherein R1 and R2 may be the same or different and each represents a hydrogen or halogen atom), their open-ring free acid derivatives, amides and salts are disclosed. A process for preparing the above-described compounds from known compound ML-236B is also disclosed.
Abstract:
Novel quinoline sulfonamino derivatives having a vessel smooth muscle relaxation activity as well as a platelet agglutination inhibitory activity and inhibitory activity to protein kinase A, myosin light chain kinase, proteinkinase C, and calmodulindependent proteinkinase II, but having little action or cardio function; a process for the production of the derivatives, and a pharmaceutical composition containing the derivative.